0001384101-18-000070.txt : 20180810
0001384101-18-000070.hdr.sgml : 20180810
20180810171032
ACCESSION NUMBER: 0001384101-18-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180809
FILED AS OF DATE: 20180810
DATE AS OF CHANGE: 20180810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hall Christopher M
CENTRAL INDEX KEY: 0001449535
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 181009656
MAIL ADDRESS:
STREET 1: 1401 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wf-form4_153393541595179.xml
FORM 4
X0306
4
2018-08-09
0
0001384101
VERACYTE, INC.
VCYT
0001449535
Hall Christopher M
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
President and COO
Common Stock
2018-08-09
4
M
0
4237
2.36
A
36692
D
Common Stock
2018-08-09
4
M
0
8263
2.36
A
44955
D
Common Stock
2018-08-09
4
M
0
7500
2.36
A
52455
D
Common Stock
2018-08-09
4
S
0
20000
12
D
32455
D
Stock Option (right to buy)
2.36
2018-08-09
4
M
0
4237
0
D
2020-09-27
Common Stock
4237.0
0
D
Stock Option (right to buy)
2.36
2018-08-09
4
M
0
8263
0
D
2010-09-27
Common Stock
8263.0
0
D
Stock Option (right to buy)
2.36
2018-08-09
4
M
0
7500
0
D
2021-02-22
Common Stock
7500.0
3500
D
The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018.
The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
The option became exercisable in full upon the date of the grant on February 23, 2011.
/s/ Keith Kennedy, as Attorney-in-fact
2018-08-10